Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 9
Submit an article Journal homepage
648
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

A phase 2 clinical trial of eltrombopag for treatment of patients with myelodysplastic syndromes after hypomethylating-agent failure

Mahesh SwaminathanDepartment of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Gautam BorthakurDepartment of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA; ORCID Iconhttp://orcid.org/0000-0001-7679-6453View further author information
ORCID Icon,
Tapan M. KadiaDepartment of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Alessandra FerrajoliDepartment of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Yesid AlvaradoDepartment of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Naveen PemmarajuDepartment of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Kristy BoddenDepartment of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Brittany YearbyDepartment of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Marina KonoplevaDepartment of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA; View further author information
,
Joseph KhouryDepartment of Hematopathology, University of Texas, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Carlos Bueso-RamosDepartment of Hematopathology, University of Texas, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Guillermo Garcia-ManeroDepartment of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA; View further author information
&
Courtney D. DiNardoDepartment of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA; Correspondence[email protected]
View further author information
 show all
Pages 2207-2213 | Received 12 Nov 2018, Accepted 28 Jan 2019, Published online: 18 Feb 2019

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Francesco D’Alò, Ilaria Zangrilli, Elisa Cupelli, Luana Fianchi, Marianna Criscuolo, Giulia Falconi, Emiliano Fabiani, Livio Pagano, Stefan Hohaus & Valerio De Stefano. (2021) In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome. Platelets 32:3, pages 378-382.
Read now
Vu H. Duong, Najla Al Ali, Ling Zhang, Eric Padron, David Sallman, Jeffrey E. Lancet, Alan F. List & Rami S. Komrokji. (2020) A sequential two-stage dose escalation study of eltrombopag in patients with myelodysplastic syndrome and thrombocytopenia after hypomethylating agent failure. Leukemia & Lymphoma 61:8, pages 1901-1907.
Read now
Namrata S. Chandhok, Russell Lewis & Thomas Prebet. (2020) Hypomethylating agent based combinations in higher risk myelodysplastic syndrome. Leukemia & Lymphoma 61:5, pages 1012-1027.
Read now

Articles from other publishers (4)

Lei Huang, Mengyue Tian, Zhaoyun Liu, Chunyan Liu & Rong Fu. (2023) Deferasirox Combination with Eltrombopag Shows Anti-Myelodysplastic Syndrome Effects by Enhancing iron Deprivation–Related Apoptosis. Journal of Investigative Medicine 70:4, pages 953-962.
Crossref
Marco Capecchi, Fabio Serpenti, Juri Giannotta, Loredana Pettine, Gianluigi Reda, Ida Martinelli, Andrea Artoni, Wilma Barcellini & Bruno Fattizzo. (2021) Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature. Frontiers in Oncology 11.
Crossref
Andrew T. Kuykendall & Eric Padron. (2019) Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO. Current Hematologic Malignancy Reports 14:6, pages 543-549.
Crossref
James Bussel, Austin Kulasekararaj, Nichola Cooper, Amit Verma, Ulrich Steidl, John W. Semple & Britta Will. (2019) Mechanisms and therapeutic prospects of thrombopoietin receptor agonists. Seminars in Hematology 56:4, pages 262-278.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.